A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Santen Inc.
Age
1–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
glaucoma or ocular hypertension
You may not be if
Females who are pregnant, nursing, or planning a pregnancy
Any corneal abnormality or other condition interfering with or preventing reliable tonometric measurements
Clareo Health | A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
